Test Price
1,000 AED✅ Home Collection Available
Hain’s Mycobacterium Tuberculosis Second-Line Drug Resistance Profile Test in UAE | 1000 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical & Operational Excellence – DHA‑Compliant Second‑Line TB Resistance Profiling
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited processing with stringent internal quality controls.
- Hospital-Only Sample Collection – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance – Complimentary telephonic post‑test result interpretation by a DHA‑licensed specialist in medical genetics.
- Insurance Direct Billing – WhatsApp verification at +971 54 548 8731.
Test Overview & Methodology
The Hain’s MTB second‑line drug resistance profile utilises advanced line‑probe assay technology after PCR amplification to rapidly detect mutations in genes conferring resistance to fluoroquinolones, aminoglycosides, and injectable second‑line agents. This molecular approach provides results in days rather than weeks, enabling clinicians to tailor therapy for multi‑drug resistant tuberculosis (MDR‑TB) with precision.
| Parameter | Our Test (Line Probe Assay + PCR) | Closest Alternative (Culture‑based DST) |
|---|---|---|
| Methodology | PCR + GenoType MTBDRsl (Hain LifeScience) | MGIT 960 phenotypic sensitivity |
| Drugs Covered | Fluoroquinolones, kanamycin, amikacin, capreomycin, ethionamide | Variable, slow turn‑around; may miss low‑level resistance |
| Turn‑Around Time | 5 days (sample by Sat 11 am, report Fri) | 4–8 weeks |
| Clinical Utility | Rapid guidance for second‑line regimen in MDR‑TB | Definitive but delays initiation of appropriate therapy |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I recognise that waiting for drug resistance results is a time of intense anxiety. This molecular profile provides rapid and reliable genetic information, but it must always be correlated with your full clinical picture. Never discontinue or alter your anti‑TB medications without first consulting your DHA‑licensed doctor.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Warning
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Inability to produce an adequate sputum/BAL sample; active massive hemoptysis; severe uncontrolled bronchospasm.
- Emergency Red Flags: Acute shortness of breath at rest, fever >39°C with confusion, signs of sepsis, or severe chest pain. Seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does this test detect?
This molecular test detects genetic mutations causing resistance to key second‑line TB drugs, such as fluoroquinolones and injectable agents. The results help your doctor choose the most effective treatment regimen for MDR‑TB.
2. How is the sample collected?
Sample collection must be performed in a hospital setting. A licensed healthcare professional will collect sputum, bronchoalveolar lavage (BAL), or other respiratory specimen. Home collection is not available for this test due to safety requirements.
3. How accurate is this resistance profile?
The assay achieves over 99% sensitivity and specificity for detecting resistance mutations, validated under strict ISO 9001:2015 quality management standards.
UAE Regulatory & Data Privacy Adherence
Compliance & Accreditation
All testing is performed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Laboratory: DNA Labs UAE
Clinical & Logistical Metadata
| Test Name | Hain’s Mycobacterium Tuberculosis Second-Line Drug Resistance Profile |
| Price (AED) | 1000 |
| Turnaround Time | 5 days (sample cut-off Saturday 11 am, report following Friday) |
| Sample Type / Matrix | Sputum, bronchoalveolar lavage (BAL), bronchial aspirate, or cultured growth. Hospital extraction only. Transport refrigerated, do not freeze. |
| Methodology Used | PCR + GenoType MTBDRsl (Hain LifeScience) line probe assay |
| ICD-10-CM Code | Z16.23 (Resistance to multiple anti-infectives) |
| LOINC Code | 75274-1 (Mycobacterium tuberculosis complex drug susceptibility panel) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians